Welcome to Agility Advisors

Hello, I am Dr. Steven Barefoot, the founder of Agility Advisors. Thank you for visiting our site. At Agility Advisors, we aim to be more than just consultants; we strive to be your innovative partner in navigating the complexities of Medicaid dental benefits. I am a licensed dentist with over nine years in the dental benefits administration field primarily focused on designing value based payment programs and contributing to RFP responses. This experience, combined with significant achievements in diverse fields like technology, analytics, and education, allows me to bring a unique perspective to finding innovative solutions to transform your challenges into opportunities.

Our Expertise

  • Comprehensive Healthcare and Dental Benefits Management: Expertise in enhancing care delivery and operational efficiencies within Medicaid dental programs.

  • Advanced Data Analytics: Proficient in advanced statistical methods and predictive modeling, including the use of cluster analysis and Monte Carlo simulations, to deliver insightful analyses of complex healthcare data.

  • Technology and AI Integration: Deep experience in integrating AI into RFP processes and decision-making frameworks, drawing from my role as a former National Solution Director for an international IT consulting firm.

  • Cross-Industry Innovation: My non-dental experiences are vital to our approach. These include:

    • Environmental Science: As Vice President of Science and Technology at an environmental consulting firm, I led innovative projects focused on environmental forensics and sustainable solutions.

    • Educational Leadership: I founded and directed an internationally recognized authorized education center for IBM-Lotus Notes, equipping professionals with cutting-edge skills in technology and collaboration.

    • Clinical and Medical Research: My research work in cardiovascular studies and phase three clinical trials has honed my ability to apply scientific methods to real-world healthcare challenges.

Highlights of Our Unique Approach

  • Interdisciplinary Healthcare and Technology Expertise: As a former National Solution Director for an international IT consulting firm and a pioneer in the application of AI in healthcare management, I bring a rare blend of technical acumen and healthcare insight.

  • Advanced Educational Initiatives: I founded and led an internationally recognized educational center authorized by IBM-Lotus Notes, which became a cornerstone for professional development in advanced system administration and application development.

  • Innovative Research and Development: My research as a Cardiovascular Research Fellow involved studying reactive oxygen species and their impacts on systemic health, providing a strong foundation in medical science that enhances our approach to healthcare consulting.

  • Environmental and Corporate Strategy: As Vice President of Science and Technology at an environmental consulting firm, I led initiatives using hydrocarbon fingerprinting to address groundwater contamination.

  • Clinical Trials and Medical Research Software Development: I founded a software company that developed systems to manage clinical trials, emphasizing my capability to bridge the gap between technology and healthcare.

  • Strategic RFP Design and Analysis: My experience extends to managing responses for major healthcare and technology projects, ensuring alignment with strategic objectives.

  • Teaching and Thought Leadership: Teaching at Chaplain College, I focus on Clinical Systems Management, Health Care Performance Innovation, and Project Management.

  • Corporate Insight and Innovation: As CIO and chief scientist at an environmental firm in Florida, I spearheaded forensic investigations that blended technology with scientific inquiry.

Engage with Agility Advisors

Discover the difference that broad expertise and innovative thinking can make. Let’s redefine what's possible in Medicaid dental benefits together. [Contact Us] to start a conversation about your needs and our solutions.

Publications

  1. Barefoot, S., & Linson, M. (2024). Value-based care and the sustainable dental practice. The Journal of the American Dental Association, 155(9), 731-732.

  2. Barefoot, S., & Linson, M. (2023). Performance measures in oral health.

  3. Fiehn, R., Okunev, I., Bayham, M., Barefoot, S., & Tranby, E. P. (2020). Emergency and urgent dental visits among Medicaid enrollees from 2013 to 2017. BMC Oral Health, 20, 1-7.

  4. Barefoot, S. (2019). A prescription to improve the health of Hoosiers: A second medical school in Indiana. LinkedIn. Accessed online.

  5. Barefoot, S. (2017). Weak ties are the foundation of an adaptive organization. LinkedIn. Accessed online.

  6. Barefoot, S. (2016). The telecoms evolution: how the operator becomes the digital telco. Digitalisation World. Accessed online.

  7. Barefoot, S. (2016). Understanding REAL customer expectations could change everything for MNOs. Telecoms. Accessed online.

  8. Barefoot, S. (2016). NFV as an enabler of new revenue streams for mobile operators. Vanilla Plus. Accessed online.

  9. Barefoot, S. (2016). Are the towers ready to fall? South African Wireless Communications. Accessed online.

  10. Barefoot, S. (2014). Has RCS "Crossed the Chasm?" Interop Technologies - Analyst Corner. Accessed online.

  11. (1989). Small business and personal computers: Making sense of data management options. Indianapolis Business Journal, 10(27), 9-15.

  12. Kleinhans, F. W., & Barefoot, S. T. (1987). Spin trap determination of free radical burst kinetics in stimulated neutrophils. Journal of Biological Chemistry, 262(26), 12452-12457.

  13. Barefoot, S. T., Demeter, R. J., & Toth, P. D. (1987). Cardiac-output measurements determined by thermodilution and a nasogastric impedance catheter in the dog. Clinical Research, 35(3), A261-A261.

  14. Hunt, D. A., & Barefoot, S. T. (1987). Effect of various platelet-activating-factor (PAF) antagonists on neutrophil degranulation. Clinical Research, 35(3), A478-A478.

  15. Demeter, R. J., Ward, D., Blevins, W., Barefoot, S. T., Hawk, C. T., et al. (1987). Cardiac-output measurements determined by thermodilution and a nasogastric impedance catheter in the pony. Federation Proceedings, 46(3), 356-356.

  16. Barefoot, S. T., Demeter, R. J. (1987). Nasogastric impedance catheter measurement of cardiac output in the dog. Proceedings of the seventh international conference on electrical bioimpedance.

  17. Bhagwandin, B. D., Kleinhans, F. W., & Barefoot, S. T. (1986). Kinetics of hydroxyl radical (OH.) production from stimulated neutrophils. Federation Proceedings, 45(3), 308-308.

  18. Barefoot, S. T. (1986). CV3988, a platelet-activating-factor (PAF) analog, selectively inhibits neutrophil aggregation. Federation Proceedings, 45(3), 308-308.

  19. Salaris, S. C., & Barefoot, S. T. (1986). An improved method for measuring lysozyme. Proceedings of the Indiana Academy of Science, 95.

  20. Hill, M., Kleinhans, F. W., & Barefoot, S. T. (1986). Determination of OH• production by stimulated neutrophils using ESR spectroscopy. Proceedings of the Indiana Academy of Science, 95.

  21. Bhagwandin, B. F. W., & Barefoot, S. T. (1986). Lag time of OH• radical production by zymosan stimulated neutrophils. Proceedings of the Indiana Academy of Science, 95.

  22. Toth, P. D., Barefoot, S. T., DiMicco, J. A., & Judy, W. V. (1985). The effects of different mediator antagonists on hemorrhagic-shock in the pithed rat. Federation Proceedings, 44(5), 1574-1574.

  23. Kleinhans, F. W., & Barefoot, S. T. (1985). Kinetics of the neutrophil metabolic burst via electron-spin-resonance. Biophysical Journal, 47(2), A405-A405.

  24. Barefoot, S. T., Kleinhans, F. W., & Toth, P. D. (1985). Platelet activating factor (PAF) activation of neutrophils is selectively blocked by a PAF analog. Federation Proceedings, 44(4), 1041-1041.

  25. Berkow, R. L., Weisman, S. J., Tzeng, D., Haak, R. A., Kleinhans, F. W., Barefoot, S., ... (1984). Comparative responses of human polymorphonuclear leukocytes obtained by counterflow centrifugal elutriation and Ficoll-Hypaque density centrifugation: II. Membrane potential. The Journal of laboratory and clinical medicine, 104(5), 698-710.

  26. Barefoot, S. T., & Kleinhans, F. W. (1984). Inhibition of neutrophil aggregation by non-steroidal antiinflammatory agents. Proceedings Indiana Academy of Science.

  27. Toth, P. D., Hamburger, S. A., Barefoot, S. T., & Judy, W. V. (1984). The effects of thyroid releasing hormone (TRH) on hemorrhagic-shock in dogs. Federation Proceedings, 43(4), 1027-1027.

  28. Barefoot, S. T., Toth, P. D., Kleinhans, F. W., & Hamburger, S. A. (1984). Hydroxyl radical production by neutrophils-effect of endotoxic-shock. Circulatory Shock, 13(1), 56-57.

  29. Barefoot, S. T., & Kleinhans, F. W. (1984). Phorbol-myristate acetate reduces calcium requirements for neutrophil stimulation. Federation Proceedings, 43(4), 818-818.

  30. Kleinhans, F. W., Barefoot, S. T., & Hawley, D. A. (1984). Localization of hydroxyl radical production in stimulated PMN using EPR. Biophysical Journal (Abstract), 45, 242a.

  31. Hawley, D. A., Kleinhans, F. W., & Biesecker, J. L. (1983). Determination of alternate pathway complement kinetics by electron spin resonance spectroscopy. American Journal of Clinical Pathology, 79(6), 673-677.

  32. Toth, P. D., Hamburger, S. A., Barefoot, S. T., & Judy, J. W. (1983). The effects of different vasoactive mediator antagonists on hemorrhagic shock in dogs. Physiologist, 26(4), A-75.

  33. Barefoot, S. T., & Kleinhans, F. W. (1982). EPR assay of the metabolic burst of polymorphonuclear leukocytes. Bulletin of the American Physical Society, 18(6), 904.

Agility Advisors is part of the Agility Group